Betaclav-DDS
Amoxycillin & Potassium Clavulanate Oral Suspension IP 457 mg
“ Dual Power Against Bacterial Infections ”
Product Overview
BETACLAV-DDS Dry Syrup is a broad-spectrum pediatric antibiotic formulation designed to effectively treat a wide range of bacterial infections. The combination of Amoxycillin and Potassium Clavulanate provides enhanced antibacterial coverage by eliminating susceptible bacteria and overcoming beta-lactamase-mediated resistance, ensuring effective infection control and faster recovery in children.
🔬 Mechanism of Action (Ingredients)
✦ Amoxycillin (400 mg)
- Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
- Causes bacterial cell lysis leading to rapid bacterial death.
- Provides broad-spectrum activity against susceptible Gram-positive and Gram-negative bacteria.
- Effectively reduces bacterial load and controls infection.
✦ Potassium Clavulanate (57 mg)
- Acts as a beta-lactamase inhibitor, protecting Amoxycillin from enzymatic degradation.
- Restores the antibacterial activity of Amoxycillin against resistant organisms.
- Expands the antibacterial spectrum against beta-lactamase-producing bacteria.
- Enhances overall treatment efficacy and infection clearance.
🎯 Approved Clinical Indications
• Ear, Nose & Throat (ENT) Infections
• Acute Otitis Media
• Respiratory Tract Infections
• Tonsillitis & Pharyngitis
• Urinary Tract Infections (UTIs)
• Skin & Soft Tissue Infections
📦 Product Packaging
📊 Clinical Efficacy & Study Data
Comparative clinical charts derived from pharmacokinetics data showing efficacy parameters.